Pericardial Fat Volume Correlates With Inflammatory Markers: The Framingham Heart Study

[1]  Anders Larsson,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.

[2]  M. Prokop,et al.  Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. , 2008, European heart journal.

[3]  Udo Hoffmann,et al.  Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.

[4]  C. Hsieh,et al.  Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease , 2008, International Journal of Obesity.

[5]  V. Positano,et al.  Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat , 2008, Hypertension.

[6]  J. Murabito,et al.  Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress: The Framingham Heart Study , 2007, Circulation.

[7]  Udo Hoffmann,et al.  Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.

[8]  W. Koenig,et al.  Biomarkers of Atherosclerotic Plaque Instability and Rupture , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[9]  E. Haynes,et al.  Biomarkers of obesity and subsequent cardiovascular events. , 2007, Epidemiologic reviews.

[10]  P. Iozzo,et al.  Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. , 2006, The Journal of clinical endocrinology and metabolism.

[11]  S. Svacina,et al.  Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. , 2006, The Journal of clinical endocrinology and metabolism.

[12]  J. Cracowski,et al.  Cardiovascular pharmacology and physiology of the isoprostanes , 2006, Fundamental & clinical pharmacology.

[13]  P. Pellikka,et al.  Subepicardial adipose tissue and the presence and severity of coronary artery disease. , 2006, Atherosclerosis.

[14]  R. Bonser,et al.  Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease , 2006, Cardiovascular diabetology.

[15]  P. Meda,et al.  Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis? , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Montani,et al.  Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. , 2005, American journal of physiology. Heart and circulatory physiology.

[17]  F. Leonetti,et al.  Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. , 2005, Cytokine.

[18]  D. Corradi,et al.  The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[19]  F. Leonetti,et al.  Relation between epicardial adipose tissue and left ventricular mass. , 2004, The American journal of cardiology.

[20]  M. Lombardi,et al.  Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function , 2004, Hypertension.

[21]  Jane B Shofer,et al.  Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. , 2004, Diabetes.

[22]  M. Rutter,et al.  C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study , 2004, Circulation.

[23]  A. Gotto,et al.  Inflammation in Atherosclerosis and Implications for Therapy , 2004, Circulation.

[24]  W. Markiewicz,et al.  Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome , 2004, International Journal of Obesity.

[25]  T. Horbach,et al.  Comparison of leptin gene expression in different adipose tissues in children and adults. , 2004, European journal of endocrinology.

[26]  B. Goldstein,et al.  Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators , 2003, Circulation.

[27]  F. Leonetti,et al.  Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. , 2003, The Journal of clinical endocrinology and metabolism.

[28]  B. W. Bakkum.  The Developing Human: Clinically Oriented Embryology, 7th ed. , 2003 .

[29]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[30]  F. Leonetti,et al.  Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. , 2003, Obesity research.

[31]  D. Bastelica,et al.  Relationships between Fibrinolytic and Inflammatory Parameters in Human Adipose Tissue: Strong Contribution of TNFα Receptors to PAI-1 Levels , 2002, Thrombosis and Haemostasis.

[32]  Y. Matsuzawa,et al.  [Visceral fat]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[33]  J. Takasu,et al.  Pericardial fat accumulation in men as a risk factor for coronary artery disease. , 2001, Atherosclerosis.

[34]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[35]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[36]  L. Beilin,et al.  Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass Spectrometry , 1999 .

[37]  L. Beilin,et al.  Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. , 1999, Analytical biochemistry.

[38]  G A Colditz,et al.  Abdominal adiposity and coronary heart disease in women. , 1998, JAMA.

[39]  R. McPherson,et al.  Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. , 1998, Atherosclerosis.

[40]  C. Pond,et al.  Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. , 1989, Comparative biochemistry and physiology. B, Comparative biochemistry.

[41]  K. L. Moore,et al.  The developing human , 1988 .

[42]  Y. Shimada,et al.  Formation of the epicardium studied with the scanning electron microscope. , 1978, Developmental biology.

[43]  K. L. Moore,et al.  The Developing Human: Clinically Oriented Embryology , 1973 .